Clinical Scorecard: First 20mL Universal Plunger for Large-Volume On-Body Delivery
At a Glance
| Category | Detail |
|---|---|
| Condition | Large-Volume Drug Delivery |
| Key Mechanisms | Slow, controlled drug delivery via subcutaneous administration. |
| Target Population | Patients requiring high-dose biologics for self-administration. |
| Care Setting | At-home administration. |
Key Highlights
- Expansion of NeoFlex™ range with a 20mL plunger for large-volume cartridges.
- Supports a wider range of self-administration devices.
- Compatible with all 20mL ISO cartridges on the market.
- Non-fluorosurfactant grade fluoropolymer coating ensures safety and compatibility.
- Addresses challenges in high-dose and high-volume biologics delivery.
Guideline-Based Recommendations
Diagnosis
Management
- Utilize NeoFlex™ plungers for controlled delivery of high-dose therapies.
Monitoring & Follow-up
Risks
- Potential exposure to extractables and leachables if not using compatible components.
Patient & Prescribing Data
Patients requiring large-volume subcutaneous drug delivery.
Facilitates at-home administration, enhancing patient comfort.
Clinical Best Practices
- Implement standardized large-volume delivery solutions to reduce complexity.
- Collaborate with pharmaceutical and medical device manufacturers for improved patient care.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
